Frank Newby
Nephrology · Dalton, GANPI 1801889696
Payments from drug & device makers
Across 481 payments — averaging $113.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Akebia Therapeutics Inc$46K
- OPKO Pharmaceuticals, LLC$996
- AstraZeneca$941
- Otsuka America Pharmaceutical, Inc.$846
- Amgen$740
- Fresenius USA Marketing, Inc.$629
- plus $4K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Akebia Therapeutics Inc | 35 | $46,460 |
| OPKO Pharmaceuticals, LLC | 102 | $996 |
| AstraZeneca(2 entities) | 51 | $941 |
| Otsuka America Pharmaceutical, Inc. | 39 | $846 |
| Amgen(2 entities) | 38 | $740 |
| Fresenius USA Marketing, Inc. | 29 | $629 |
| Bayer | 34 | $623 |
| Travere Therapeutics, Inc. | 29 | $440 |
| Vifor Pharma, Inc. | 18 | $363 |
| Novo Nordisk | 9 | $312 |
| Novartis | 10 | $252 |
| ANI Pharmaceuticals, Inc. | 10 | $209 |
| Calliditas Therapeutics US Inc. | 10 | $208 |
| Ardelyx, Inc. | 10 | $205 |
| Mallinckrodt Hospital Products Inc. | 6 | $164 |
| Aurinia Pharma U.S., Inc. | 4 | $103 |
| Baxter Healthcare | 1 | $100 |
| Daiichi Sankyo Inc. | 3 | $86 |
| GSK | 6 | $85 |
| Boehringer Ingelheim | 5 | $83 |
| AbbVie(2 entities) | 4 | $64 |
| Genentech USA, Inc. | 4 | $61 |
| Scpharmaceuticals Inc. | 4 | $59 |
| Cormedix Inc. | 2 | $58 |
| Shire North American Group Inc | 3 | $44 |
| AMAG Pharmaceuticals, Inc. | 3 | $43 |
| Lilly USA, LLC | 2 | $43 |
| Mallinckrodt Enterprises LLC | 2 | $42 |
| Medtronic | 1 | $38 |
| Sanofi | 1 | $22 |
| Averitas Pharma Inc. | 1 | $21 |
| Shield Therapeutics Inc | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Vantive US Healthcare LLC | 1 | $16 |
| Johnson & Johnson | 1 | $16 |
| Strongbridge US Inc. | 1 | $12 |
How this compares
$54,420 in reported general payments places this provider in the 85th percentile of 388 nephrology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in Dalton
- James TumlinLawrenceville$19.8M
- Chinedu NwekeAcworth$3.9M
- Vinayak RamanathLagrange$3.1M
- Harold HubertAugusta$2.8M
- Tamorie SmithColumbus$1.9M
- Barton BrezinaAugusta$1.5M
- Frederic Rahbari OskouiAtlanta$1.5M
- Rajeev ChauhanColumbus$1.1M
- Sagar PanseMacon$1.1M
- Laura MulloyAugusta$891K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.